Tandem Diabetes Care, Inc. Accumulated Other Comprehensive Income
Tandem Diabetes Care, Inc. (TNDM) had Accumulated Other Comprehensive Income of $6.40 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $6.40M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.04M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.59M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.17M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $6.40M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $5.04M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $5.59M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $5.17M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $3.75M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $75.00K 10-Q · filed 2025-04-30 |
| 2024-12-31 | -$1.95M 10-K · filed 2026-02-19 |
| 2024-09-30 | $3.87M 10-Q · filed 2024-11-06 |
| 2024-06-30 | -$1.25M 10-Q · filed 2024-08-01 |
| 2024-03-31 | -$935.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.37M 10-K · filed 2025-02-26 |
| 2023-09-30 | -$2.21M 10-Q · filed 2023-11-01 |
| 2023-06-30 | -$1.19M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$93.00K 10-Q · filed 2023-05-03 |
| 2022-12-31 | -$1.82M 10-K · filed 2024-02-21 |
| 2022-09-30 | -$5.06M 10-Q · filed 2022-11-02 |
| 2022-06-30 | -$4.28M 10-Q · filed 2022-08-03 |
| 2022-03-31 | -$3.06M 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$616.00K 10-K · filed 2023-02-22 |
| 2021-09-30 | $14.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $29.00K 10-Q · filed 2021-08-04 |
| 2021-03-31 | $106.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $220.00K 10-K · filed 2022-02-22 |
| 2020-09-30 | $190.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $43.00K 10-Q · filed 2020-07-30 |
| 2020-03-31 | -$245.00K 10-Q · filed 2020-04-30 |
| 2019-12-31 | $122.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $91.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $162.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $41.00K 10-Q · filed 2019-04-30 |
| 2018-12-31 | -$13.00K 10-K · filed 2020-02-24 |
| 2018-09-30 | -$13.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $6.00K 10-Q · filed 2018-07-30 |
| 2016-12-31 | -$1.00K 10-K · filed 2018-03-01 |
| 2016-09-30 | -$3.00K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $3.00K 10-Q · filed 2016-07-28 |
| 2016-03-31 | $40.00K 10-Q · filed 2016-04-28 |
| 2015-12-31 | $20.00K 10-K · filed 2017-03-08 |
| 2015-09-30 | $32.00K 10-Q · filed 2015-10-29 |
| 2015-06-30 | $37.00K 10-Q · filed 2015-07-30 |
| 2015-03-31 | $39.00K 10-Q · filed 2015-04-30 |
| 2014-12-31 | $8.00K 10-K · filed 2016-02-24 |
| 2014-09-30 | $18.81K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $12.28K 10-Q · filed 2014-07-31 |
| 2014-03-31 | $13.83K 10-Q · filed 2014-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |